Skip to main content
Fig. 8 | Genome Biology

Fig. 8

From: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Fig. 8

Immune infiltration profiles in nivolumab-treated ccRCC patients. RNA-Seq profiles of six ccRCC patients were generated and the patients were then treated with the checkpoint inhibitor nivolumab (anti-PD1). T cell infiltration as well as APM, IFNG, and GZMB levels are generally high in responders (complete response, partial response, or stable disease) and the highest levels are observed in the patient with complete response

Back to article page

Genome Biology

ISSN: 1474-760X

Contact us